StockData
Atea Pharmaceuticals, Inc. logo

Atea Pharmaceuticals, Inc. (AVIR) stock

AVIRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$3.99+0.03 (+0.76%)

Close on Nov 18, 2026Market cap $320.02MP/E –Yield –

Atea Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Atea Pharmaceuticals's pe ratio was 13.2× on Jan 31, 2023, against 24.0× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jan 31, 202313.2×−0.5
2022Dec 30, 202213.7×−16.3
2021Dec 31, 202130.0×–

More Atea Pharmaceuticals figures

See a number that looks wrong?